Filter
1663
Text search:
national
drug
authority
Featured
133
542
Language
Document type
974
242
225
99
69
21
18
8
2
2
1
1
Countries
100
80
71
67
49
47
44
44
42
42
36
35
34
33
32
31
26
24
24
22
19
18
18
17
15
13
12
10
10
9
9
8
8
8
7
6
6
6
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
848
88
69
67
48
30
24
Toolboxes
132
119
107
106
64
61
39
35
27
26
26
26
24
23
23
20
19
16
10
9
9
8
8
7
2
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit
...
EU and Global Governance for Health - How EU global policies impact health
Ethiopia Antimicrobial Resistance Surveillance Plan
WHO/UNICEF/UNFPA joint statement
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
